The studies by Karlsen et al. 22 and Gaj et al. 23 did not show an impact of NOD2 variants on the development of primary sclerosing cholangitis (PSC) or primary biliary cholangitis (PBC), respectively. This evidence concerns the gene NOD2 and sclerosing cholangitis.